Endoscopic findings of immune checkpoint inhibitor-related gastrointestinal adverse events

The use of immune checkpoint inhibitors (ICIs) for the treatment of various malignancies is increasing. Immune-related adverse events can occur after ICI administration, with gastrointestinal adverse events constituting a significant proportion of these events. When ICI-related diarrhea/colitis is s...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Clinical Endoscopy
المؤلفون الرئيسيون:	Min Kyu Kim, Sung Wook Hwang
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Korean Society of Gastrointestinal Endoscopy 2024-11-01
الموضوعات:	drug-related side effects and adverse reactions endoscopy, gastrointestinal histology immune checkpoint inhibitors
الوصول للمادة أونلاين:	http://www.e-ce.org/upload/pdf/ce-2024-003.pdf

مواد مشابهة

Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a review
حسب: Sung Wook Hwang, وآخرون
منشور في: (2023-10-01)

Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
حسب: Hamzah Abu-Sbeih, وآخرون
منشور في: (2018-09-01)

Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review
حسب: Elizabeth S Mearns, وآخرون
منشور في: (2018-03-01)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated adverse events in the digestive system
حسب: Yue Li, وآخرون
منشور في: (2020-04-01)

Clinical Diagnosis and Treatment of Immune-related Adverse Events in Digestive System Related to Immune Checkpoint Inhibitors
حسب: Yue LI, وآخرون
منشور في: (2019-10-01)

Endoscopic Findings of Upper Gastrointestinal Involvement in Primary Vasculitis
حسب: Eun Jeong Gong, وآخرون
منشور في: (2016-07-01)

Immune checkpoint inhibitors⁃related nervous system adverse events
حسب: WANG Ze⁃yi, وآخرون
منشور في: (2022-09-01)

Comparison of hemodynamics and respiratory function between ciprofol-remifentanil and propofol-remifentanil in obese patients undergoing gastrointestinal endoscopic anesthesia: a randomized controlled trial
حسب: Chunfang Jian, وآخرون
منشور في: (2025-10-01)

Baseline profile peripheral Tfh cells predict immune-related adverse events in immune checkpoint inhibitor therapy of gastrointestinal cancer
حسب: Yifan Wang, وآخرون
منشور في: (2025-05-01)

Predictors of positive endoscopic findings in hospitalized patients with occult gastrointestinal bleeding
حسب: Neil Sengupta, وآخرون
منشور في: (2015-12-01)

Upper gastrointestinal endoscopic findings in children at rapareen teaching hospital in Erbil, Iraq
حسب: Dlair Abdulkhaleq Chalabi
منشور في: (2020-01-01)

Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy
حسب: Prasanna Duraisamy, وآخرون
منشور في: (2023-07-01)

Characterizing immune checkpoint inhibitor-related cutaneous adverse reactions: A comprehensive analysis of FDA adverse event reporting system (FAERS) database
حسب: Buğra Han Esen, وآخرون
منشور في: (2024-07-01)

Sedation-related adverse events in gastrointestinal endoscopy (CH-ESC study): study protocol for a prospective, observational cohort study in a Chinese tertiary hospital
حسب: Jun Lu, وآخرون
منشور في: (2025-09-01)

Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: A Minireview of Current Clinical Guidelines
حسب: Saralinh Trinh, وآخرون
منشور في: (2019-01-01)

Immune checkpoint inhibitor-induced endocrinopathies: a possible indicator of improved survival
حسب: Mariana Ornelas, وآخرون
منشور في: (2023-07-01)

Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
حسب: Linyang Gan, وآخرون
منشور في: (2023-03-01)

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
حسب: Maria Luisa De Perna, وآخرون
منشور في: (2025-08-01)

Cutaneous adverse events due to checkpoint inhibitors – a retrospective analysis at a tertiary referral hospital in Switzerland 2019-2022
حسب: Clara Furrer-Matcau, وآخرون
منشور في: (2024-12-01)

Clinical analysis of 22 cases of cutaneous adverse reactions caused by molecular targeted antitumor agents and immune checkpoint inhibitors
حسب: Kui MU, وآخرون
منشور في: (2023-12-01)

Pancreatic adverse events in patients treated with immune checkpoint inhibitors
حسب: Caroline Hana, وآخرون
منشور في: (2023-03-01)

Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
حسب: Jiaxin ZHOU, وآخرون
منشور في: (2019-10-01)

Neurologic adverse events of cancer immunotherapy
حسب: Marcelo Houat de Brito
منشور في: (2022-08-01)

Immune Checkpoint Inhibitors in Breast Cancer: A Narrative Review
حسب: Paulo Nunes Filho, وآخرون
منشور في: (2023-03-01)

Preclinical Assessment of Tissue Effects by Gastrointestinal Endoscope Tip Temperature
حسب: Luise Jäger, MSc, وآخرون
منشور في: (2023-01-01)

Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract
حسب: Michael Dougan
منشور في: (2017-11-01)

Correlation of the gut microbiome and immune-related adverse events in gastrointestinal cancer patients treated with immune checkpoint inhibitors
حسب: Yifan Zhang, وآخرون
منشور في: (2023-03-01)

Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events
حسب: Peng Song, وآخرون
منشور في: (2020-08-01)

Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma
حسب: Hanna Karhapää, وآخرون
منشور في: (2022-02-01)

Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
حسب: Parneet K. Cheema, وآخرون
منشور في: (2024-10-01)

Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events
حسب: Junling ZHUANG, وآخرون
منشور في: (2019-10-01)

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
حسب: Junling Zhuang, وآخرون
منشور في: (2020-03-01)

The assessment of rheumatologic immune-related adverse events with immune checkpoint inhibitors
حسب: Emre Tekgöz, وآخرون
منشور في: (2022-03-01)

Advances in Predictive Research of Immune Checkpoint Inhibitors-related  Adverse Events
حسب: Jing ZHANG, وآخرون
منشور في: (2023-10-01)

Clinical characteristic analysis of immune checkpoint inhibitor-related pituitary adverse events
حسب: Yufan ZHENG, وآخرون
منشور في: (2025-08-01)

Ocular adverse events associated with immune checkpoint inhibitors, a scoping review
حسب: A. Martens, وآخرون
منشور في: (2023-02-01)

Endoscopic Features of Gastrointestinal Amyloidosis: A Proposed Endoscopic Classification
حسب: Joo Hye Song, وآخرون
منشور في: (2025-07-01)

Endoscopic vacuum therapy for gastrointestinal transmural defects: a literature review
حسب: Tan Minh Le, وآخرون
منشور في: (2025-03-01)

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
حسب: Lingli Luo, وآخرون
منشور في: (2023-04-01)

Management of immune checkpoint inhibitor‐related dermatologic adverse events
حسب: Xiaoyan Si, وآخرون
منشور في: (2020-02-01)